Sage Therapeutics
SAGE
#7025
Rank
ยฃ0.40 B
Marketcap
ยฃ6.49
Share price
0.00%
Change (1 day)
2.52%
Change (1 year)

Revenue for Sage Therapeutics (SAGE)

Revenue in 2025 (TTM): ยฃ53.02 Million

According to Sage Therapeutics 's latest financial reports the company's current revenue (TTM ) is ยฃ52.68 Million. In 2024 the company made a revenue of ยฃ32.86 Million a decrease over the revenue in the year 2023 that were of ยฃ67.86 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sage Therapeutics from 2013 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ53.02 M61.35%
2024 ยฃ32.86 M-51.57%
2023 ยฃ67.86 M968.03%
2022 ยฃ6.35 M35.97%
2021 ยฃ4.67 M-99.43%
2020 ยฃ0.81 B15506.99%
2019 ยฃ5.23 M-92.64%
2018 ยฃ71.11 M
2017 N/A
2016 N/A
2015 N/A
2014 N/A
2013 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Regulus Therapeutics
RGLS
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Eagle Pharmaceuticals
EGRX
ยฃ0.19 B 265.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Horizon Therapeutics
HZNP
ยฃ2.72 B 5,075.98%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Intercept Pharmaceuticals
ICPT
ยฃ0.23 B 351.19%๐Ÿ‡บ๐Ÿ‡ธ USA